Cite
HARVARD Citation
Bilyard, H. et al. (n.d.). IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bilyard, H. et al. (n.d.). IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer. Journal for immunotherapy of cancer. p. . [Online].